Table 1.

Characteristics of patients

	Diagnosis	Subgroup	N	% of total with abnormal SNP-A	% of total with UPD	% of those with abnormal SNP-A having UPD
Total (n = 301)	MDS (n = 140)	RA/RARS/RCMD/5q	67	63	18	29
		RAEB I/II	28	79	14	18
		Secondary AML	45	67	20	30
	MDS/MPD (n = 81)	MDS/MPDu	29	66	34	53
		CMML	27	74	41	55
		Secondary AML *	25	88	60	68
	MPD (n = 14)	N/a	7	100	57	57
	MPD (n = 14)	Secondary AML	7	86	57	67
	pAML (n = 66)	N/a	66	56	24	43

NOTE: Samples from 116 healthy individuals were used as controls.

Abbreviations: N/a, not applicable; pAML, primary AML.
↵* Includes patients who evolved to AML from both MDS/MPDu and CMML.